SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 58 filers reported holding SYROS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $34,000 | -66.0% | 28,582 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $100,000 | -29.1% | 30,594 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $141,000 | -19.9% | 31,509 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $176,000 | -14.6% | 32,258 | +17.3% | 0.00% | 0.0% |
Q1 2021 | $206,000 | -21.4% | 27,502 | +14.0% | 0.00% | 0.0% |
Q4 2020 | $262,000 | +19.1% | 24,133 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $220,000 | -18.8% | 24,825 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $271,000 | +122.1% | 25,390 | +23.8% | 0.00% | 0.0% |
Q1 2020 | $122,000 | -18.7% | 20,513 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $150,000 | -33.9% | 21,699 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $227,000 | +11.3% | 21,882 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $204,000 | +38.8% | 22,034 | +36.6% | 0.00% | 0.0% |
Q1 2019 | $147,000 | +58.1% | 16,132 | -3.1% | 0.00% | – |
Q4 2018 | $93,000 | -53.5% | 16,655 | -0.8% | 0.00% | -100.0% |
Q3 2018 | $200,000 | +22.7% | 16,783 | +5.2% | 0.00% | 0.0% |
Q2 2018 | $163,000 | +27.3% | 15,953 | +61.4% | 0.00% | – |
Q1 2018 | $128,000 | +56.1% | 9,883 | +17.3% | 0.00% | – |
Q4 2017 | $82,000 | -33.3% | 8,426 | +0.5% | 0.00% | – |
Q3 2017 | $123,000 | -1.6% | 8,387 | +8.1% | 0.00% | – |
Q2 2017 | $125,000 | +171.7% | 7,760 | +170.7% | 0.00% | – |
Q1 2017 | $46,000 | – | 2,867 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|